Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04929028
Title Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

anal squamous cell carcinoma

rectum squamous cell carcinoma

Therapies

Capecitabine + Mitomycin C

Nivolumab

Fluorouracil + Mitomycin C

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Montefiore Medical Center-Einstein Campus Recruiting Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus Recruiting Bronx New York 10467 United States Details
Icahn School of Medicine at Mount Sinai Recruiting New York New York 10029 United States Details
Mount Sinai Hospital Recruiting New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field